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1.







To develop a tool to support medicine-focused person-centred consultations between community 
pharmacists and stroke survivors. 
 
Method 
Semi-structured interviews with 15 stroke survivors and 16 community pharmacists were conducted.  
Thematic analysis of the data was performed and emerging themes examined to determine their 
relevance to the principles of delivering person-centred care.   Findings were used to generate a 
framework from which a consultation tool was created.  Face validity and the feasibility of using the tool 
in practice were explored with participating pharmacists. 
 
Results 
Three major themes were identified; personal, process and environmental factors.  A tool, in two parts, 
was developed, A ‘Getting to know me’ form which would help the pharmacist to appreciate the 
individual needs of the stroke survivor and a consultation guide to facilitate the consultation process.  




A consultation tool, reflecting the needs of stroke survivors, has been developed and is feasible for use 
within community pharmacy practice. 
 
Practice Implications 
Pharmacists must recognise the individual needs of stroke survivors to ensure that they provide 
consultations which are truly person-centred.    The tool developed could support medicine-related 








Stroke has reached epidemic proportions. It has been estimated that 1 in 6 people worldwide will suffer 
a stroke in their lifetime and that each year around 15 million people worldwide suffer a stroke, over 6 
million die and 5 million are left with a permanent disability.1 Surviving individuals then have a 30-43% 
chance of a recurrent stroke in the next five years.2 This risk has been calculated to be reduced by 80% 
if secondary preventative medicines (usually a minimum of an antiplatelet, statin and 
antihypertensives), lifestyle and diet changes are adhered to.3 The World Health Organisation have 
report that the benefit of improving adherence to existing medicines, for those with long-term 
conditions, may have a greater impact on their health than any future developments in medical 
treatments emphasising the importance of better medicine management.4 
 
1.1 Adherence to secondary prevention post-stroke 
Studies of adherence to secondary preventative medicines post-stroke indicate that persistence to 
medicines declines rapidly within the first two years.5-7 Longer-term adherence post-stroke is unknown. 
Research has indicated that the reasons for nonadherence in this patient population are multifactorial 
and individualised and include younger age, concerns about medications, reduced cognitive function, 
low perceived benefits of medication and practical barriers.8-10 More than half of the stroke survivors in 
a recent study reported that they needed help taking their medication and 1 in 10 had unmet medicines 
support needs.11 These findings support the need for a person-centred approach to medicines 
support.12  
 
1.2 Adopting a person-centred approach  
Although there is no single accepted definition of person-centred care, a comprehensive systematic 
review of the literature identified eight key principles.13 These relate to getting to know the individual, 
taking a holistic approach to their care, seeing the patient as the expert about their health, recognising 
autonomy and sharing decisions about care, ensuring that services are flexible to individuals’ need 
and easy to navigate, striving for continuity of services, ensuring that the physical, cultural and psycho 
social environment is conducive to delivering care, and having well trained, supportive staff.  The 
positive impact of person-centred care has been clearly demonstrated in terms of patient satisfaction 
and health outcomes14-20, but its translation into practice has been mixed, and the associated 
challenges to its adoption acknowledged.13,21-35 Concerns have been raised that more traditional, less 
patient inclusive approaches to care have prevailed in stroke rehabilitation.30.36  A search and review 
of the literature confirmed that there were no suitable tools to support pharmacists’ delivery of person-
centred medicine-focused discussions  with stroke survivors37 and that generic consultation tools  
encouraged didactic conversations which may not address  the holistic needs of these patients.10,29-52 
 
1.3 Current medicines support post-stroke 
Medicines support post-stroke is frequently limited to the provision of generic information, often at 
hospital discharge. Evaluated initiatives to support continued adherence in this patient group have 
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been primarily hospital-based and have focused on the provision of information and motivational 
interviewing in the first few months post-stroke. Most demonstrated modest short-term impact on 
adherence and clinical markers but did not address the long-term impact.53-57  The majority of stroke 
survivors are discharged from specialist care after a few months and are then cared for by a general 
practitioner with their medicines supplied by a community pharmacist.  
 
The current stroke pathway in England does not integrate medicines support into rehabilitation, yet 
stroke survivors face significant challenges when taking multiple medicines. Over half suffer physical 
(swallowing, dexterity, mobility) and cognitive (speech, memory, fatigue) deficits which can 
significantly affect their activities of daily living.58 Community pharmacists are well placed to provide 
medicines support post-discharge as they dispense medicines on a regular basis, usually monthly, 
and have the knowledge and skills required. For example, community pharmacists could ensure that 
stroke survivors receive an appropriate formulation of their medicine, or could help to establish 
individualised medicine taking routines that fit with the lifestyle and preferences of the stroke survivor. 
 
 
1.4 Research aim  
To develop a tool to support the optimal delivery of a person-centred medicine-focused consultation 
between stroke survivors (SS) and community pharmacists (CP). 
 
Specific objectives were:  To explore SS experiences of receiving medicines support and their expectations and 
perceived need for such services  To explore CP understanding of what constitutes a person-centred consultation and their 
perceptions of how to deliver such consultations in general, and specifically to a SS  To use the findings to develop a tool to support the optimisation of person-centred medicine 
consultations between SS and CP. 
 
1.5 Ethics 
Approval was gained from the Medway School of Pharmacy Ethics Committee June 2014 (REF04241). 
 
2. Methods  
2.1 Interviews 
2.1.1 Recruitment 
Inclusion and exclusion criteria for participants (SS and CP) are listed in Table 1.   
SS were recruited via three sources: Stroke Association service user groups; Age UK day centres; 
snowballing (to include independent recruits). Appropriate approval was obtained before approaching 
the user groups and day centres. After an expression of interest from a potential interviewee the 
researcher conducted a face to face meeting to offer a letter of invitation, information leaflet, establish 
eligibility for inclusion in the study, and answer any questions. This contact also enabled the researcher 
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to identify any specific requirements the SS may need during the research interview. All materials for 
SS used the Flesch-Kincaid Grade Level59 as recommended by the Stroke Association to ensure text 
readability 
 
CP were randomly selected in batches of ten from a publically available list of NHS community 
pharmacies in Kent (excluding one large national chain due to the company’s governance 
requirements). A letter of invitation which included information about the study was followed up a week 
later by a telephone call from the researcher to confirm eligibility for inclusion, and seek agreement to 
an interview. 
Written consent was obtained prior to interview for all participants. 
 
2.2 Instrumentation 
Interview schedules were developed which reflected the aims and objectives of the research for each 
participant group.  These were piloted with selected volunteers outside of the study.  
 
2.3 Data collection 
2.3.1 Stroke Survivors. Interviews were conducted at a time and place agreed with the participant a 
minimum of 72 hours following the first meeting. Formal consent was obtained, then data were collected 
on demographics and the participant’s medicines were photographed. The interviews were audio 
recorded. The interviews were not time limited and were guided by the needs of the participant. Family 
or a carer were invited to be present if the participant wished and their consent was also obtained.   
 
2.3.2 Community Pharmacists. Interviews were conducted in each pharmacist’s place of work at a 
time which suited the participant and audio recorded.  
 
The researcher recorded a personal reflection and field notes on each interview which included a 
description of the environment within which the interview had taken place. A pen portrait of each 
participant was created. All interviews were transcribed and recruitment stopped when thematic 
saturation of the data had been achieved.  
 
2.4 Data analysis 
Analysis of the data was guided by the stages of interpretative interactionism.60-62 Interpretative 
interactionism specifically seeks to understand the experience of participants during life changing 
moments and offers a person-centred approach by placing participants at the heart of the research 
process to support the development of practice. Using NVivo 10 software data were coded and 
themes generated separately for SS and CPs. Overarching themes arising from the interviews were 
then mapped to the principles of person-centred care.13 
 
2.5 Face validity testing of the tool 
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The finalised tool, which included the consultation guide and accompanying ‘Getting to know me’ 
form, were sent to all the CPs who had been interviewed together with a short form which asked for 
their views on its content and potential use in practice. The responses were analysed under the 
following headings: face validity; design, value, use, and other.  
 
3. Results 
3.1 Stroke Survivor interviews 
Twenty-two SS were screened for eligibility of which fifteen were interviewed . Of these, eight were 
recruited via the Stroke Association, four via Age UK and three were recruited independently through 
snowballing. Of the seven who were ineligible, two had suffered a haemorrhagic stroke and the 
remainder had not had a discussion with their community pharmacist within the last 12 months. The 
demographics for the interviewed SS can be seen in Table 2.  
 
All participants reported physical difficulties which restricted basic activities of daily living and the 
majority reported cognitive problems and felt that the stroke had negatively impacted on their mental 
and psychological health.  
 
Participants had varying levels of knowledge about their medicines. Two thirds of the SS had unmet 
information needs in terms of the medicines they had been prescribed post-stroke, while carers also 
expressed a need for more information.  
 
All participants expressed positive beliefs and attitudes towards their medicines, recognising that 
continued use was important to prevent a further stroke, but many expressed that the quantity 
required to be taken and the need to take them long-term was a burden to them. Although coping 
strategies for taking medicines were described by some, and all reported taking their medicines as 
prescribed, physical and cognitive problems were observed that could potentially compromise 
medicine-taking behaviours in a number of participants. The researcher observed physical problems 
that prevented patients accessing doses easily and recorded participants describing how cognitive 
difficulties sometimes led to missed doses. A number of the problems identified were amenable to 
professional help, such as altering the dosage form or packaging, but the SS had not considered 
asking for help or had difficulties accessing their pharmacy without support due to the impact of their 
stroke.  
 
Relationships between the SS and CP were explored and found to be primarily around supply of 
medicines. Most SS stated they did not know their CP as a person and that the CP did not know 
them. Some were unsure who was the pharmacist in the pharmacy they used as they saw only the 
counter staff, others had their medicines delivered as they were unable to access the pharmacy 
because of their disabilities. A number reported that they felt comfortable asking their pharmacists for 
advice related to minor ailments, but looked to their GP for information about their prescribed 
medicines. There was a general lack of awareness of the services a pharmacist could offer. Several 
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had however set in place coping strategies to manage their medicines, sometimes with the help of a 
family member, carer or health professional.  
 
Around half of the SS interviewed had experienced a sit-down consultation with a pharmacist in a 
private room, but their reported experiences were mixed. Although some rated the experience 
positively and of benefit to them, others offered more negative comments, saying the pharmacists had 
not addressed their individual needs, or had spoken too quickly for them to understand. Concerns 
were also expressed by some about how their carer had been involved. For most SS, their general 
practitioner was seen as the first port of call for medicine-related queries and the pharmacist was 
perceived as primarily the supplier of medicines, with problems associated with the efficient supply of 
medicines leading to loss of trust in the pharmacy service. Data analysis enabled a framework to be 
generated under three key themes: personal factors, process factors and environmental factors 
(Figure 1).  
 
3.2 Community Pharmacist (CP) Interviews 
Twenty-nine pharmacists were invited to participate. Sixteen agreed, were screened for eligibility and 
visited at their place of work. Of the thirteen who did not participate two were not contactable despite 
repeated attempts, nine stated they were too busy, one that management permission was needed 
and one that no regular pharmacist was working in the pharmacy. Eight interviewees were female Six 
has been qualified for less than 10 years, the remainder for longer than 10 years. Four worked in 
independent pharmacies and the remainder in multiples.   
 
Although all CPs demonstrated knowledge and understanding of person-centred care, and attitudes 
towards this approach were universally positive, the ensuing discussions frequently indicated that this 
was not practice they consistently provided during their day-to-day work in the pharmacy. The CPs 
acknowledged the need to know patients as individuals and most participants described knowing the 
majority of those who regularly used their pharmacy. They considered that their patients also knew 
them, albeit solely as a professional. It was recognised that patients who had medicines delivered to 
them as a result of their lack of mobility would not know them, as domiciliary consultations were rare, 
requiring special permission from local health managers. When asked specifically about consultations 
with SS most of the CPs interviewed were unable to recall an interview with a SS and some had a 
limited understanding of the many sequelae of a stroke which may need to be taken into account in 
order to undertake a successful consultation. 
 
The difficulties of providing person-centred care were highlighted by most CPs. Lack of time in a busy 
working environment was the key barrier to developing relationships with patients with cognitive or 
speech difficulties. The field notes of the researcher also noted the environmental difficulties that 
would compromise a discussion with a SS, including noise and small or crowded consultation rooms 
that would have difficulty accommodating a patient in a wheelchair and their carer. Most CPs were 
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very supportive of further guidance that could help them to deliver person-centred care to SSs, but 
noted that it should be concise and easy to refer to when needed to guide a consultation.  
 
The themes emerging from the interviews were summarised in a framework under the same three 
headings as used for the SS interviews (Figure 2). 
 
3.3 Development of the consultation tool 
The two frameworks developed from the interviews were used (Figures 1 and 2), together with 
findings from a literature review on this topic37, to inform the development of a tool (Figure 3) that 
comprised consultation guidance and an accompanying ‘Getting to know me” form.  
 
The ‘Getting to know me’ form reflected the importance accorded to getting to know the person as an 
individual.13 Two versions were created, a written and pictorial presentation.  The need for an 
alternate aphasia friendly form was recognised as crucial by both SS, as a result of their diverse and 
individualised needs, and also by the pharmacists. The consultation guide comprised a section 
entitled ‘Starting out’ which covered issues to consider before initiating the consultation. The second 
section ‘Getting the best from the consultation’ identified a number of issues to help optimise the 
consultation process. 
 
3.4 Face validity testing  
Fourteen of the sixteen pharmacists who had participated in the interviews were contacted. The 
remaining two had left their place of work. Eleven responded. All respondents considered the tool was 
useful for its intended purpose, considering that it would support person-centred care. Although all 
respondents recognised its value and reported they were willing to use it in practice, two raised the 
time required as a barrier to its use.  
 
4.  Discussion and Conclusion 
4.1 Discussion 
This research has reinforced the need for improved medicines support for stroke survivors and 
highlighted how person-centred medicines consultations between SS and health care professionals 
(HCPs), particularly CPs could be improved. Three areas were identified as key to a successful 
person-centred consultation about medicines with SS: the need to develop a personal relationship 
between the SS and CP/ HCP (personal factors); the need to adapt the consultation to promote SS 
understanding and ability where cognitive or physical problems may limit these (process factors); and 
the need to get the environment for the consultation right (environment factors). These were 
incorporated into a tool comprising two forms which could be used to support the practitioner initiating 
the consultation.  The tools will help to guard against the tendency for didactic education and focus 
the consultation on the specific needs of the SS thus promoting person-centred care. 
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Personal factors. The importance of having a personal relationship with health care providers who 
understand their problems and respond to their needs was clearly articulated by SS. They expected 
health care professionals to know they had had a stroke and were also happy to be asked whether 
they had had a stroke and how it affected them, but did not wish to repeat this information at every 
encounter. Yet this was not their experience and the pharmacists interviewed struggled to remember 
a consultation with a SS. The benefits to both pharmacists and their patients of developing a 
relationship have been identified in earlier studies.63-65 However, community pharmacists and other 
health care professionals or carers involved in rehabilitation and support post-stroke may not have 
ready access to clinical notes. This means that the healthcare provider will need to ask the SS directly 
about their personal circumstances. This was the rationale behind the development of a ‘Getting to 
know me’ form that could be completed by the SS or a carer. 
 
The importance of the efficient dispensing of medicines was mentioned by many SS and has been 
demonstrated to be more important than a personal relationship between patients and pharmacists in 
some studies66,67, with supply problems leading to lack of confidence or trust in the pharmacist. In this 
study, as in other studies68,69 , the SS interviewed predominantly saw pharmacists as a supplier of 
medicines and their doctor as the supplier of information and support. Many studies over the years 
have highlighted the lack of general public awareness of the role pharmacists as experts in medicines 
can play in medicines support and have emphasised the need to develop and promote better 
awareness of pharmacy services.64,70,71 
 
Although around half of the SS interviewed had experienced a private conversation with a pharmacist, 
for some these were not useful experiences. This has been reported in earlier studies. Latif noted that 
UK community pharmacists met pharmacist professional objectives rather than being patient-centred 
when undertaking consultations29, while Murad found a biomedical model approach was significantly 
more prevalent than a patient-centred focus in patient-pharmacist interactions.72 When pharmacists 
were asked themselves how they identified professionally, ‘scientist’ emerged as the strongest 
identity.63,73 . Elvey et al. reported UK pharmacists as scoring high on academic ability but relatively 
low in terms of social skills63, while Salter described pharmacists as being anxious in relation to 
patient-pharmacist communication.74 Authors world-wide have identified personality factors and 
pharmacy culture issues which impact negatively on the provision of person-centred care by 
pharmacists63,73-81 although it is suggested that recently qualified pharmacists are more prepared for, 
and open to, delivering this extended pharmacy role.76,77 
 
Process factors. Many of the community pharmacists interviewed were not aware of the diverse 
sequelae of a stroke in terms of cognitive disabilities such as aphasia, difficulty following 
conversations, or in remembering information. The interviews with SS highlighted the unmet 
medicine-support needs identified in earlier studies10,11 but also indicated that this patient group do 
not always recognise that the medicines-related problems they experience could be resolved, and 
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their information needs met. This means efforts must be made to establish exactly what problems a 
patient may have, and respond to them appropriately in the course of the consultation.  
 
Environmental factors. The importance of a suitable environment which can provide a confidential 
person-centred consultation for SS who may have mobility issues or who may need a carer to attend 
the consultation was raised by many SS. There was considerable variation in the quality of 
consultation rooms provided by the pharmacies interviewed for this study. In the pharmacies visited 
the researcher noted distractions such as clutter or background noise that could impact negatively on 
a consultation in this patient group. Guidance on factors which support a consultation with a person 
with disabilities arising from a stroke have been published.82-85  Although concerns were expressed 
about pharmacy consultation spaces in 2009, a study in 2013 noted that most had improved and 90% 
were assessed as being fit for purpose.86,87  
 
4.2 Strengths and Limitations 
Recruitment was restricted to participants within the UK county of Kent, and excluded pharmacists 
working for one national chain of pharmacies. However, a diverse sample of pharmacists were 
recruited, of varying age, ethnicity, gender, employment status and work-experience.  Stroke 
survivors were white British and therefore the experiences of other ethnicities were not explored. 
However, the stroke survivors did exhibit a broad range of disabilities and varying lengths of time 
post-stroke. Only single interviews were conducted and as a result the data reflects only the 
experience of participants at one point in time. Consultations between stroke survivors and 
community pharmacists were not actually observed, and therefore the data may have been limited by 
participants’ ability to accurately recall and articulate their experiences and perceptions. All of the 
pharmacist interviews were conducted in the Pharmacy with the majority being held in the 
consultation room.  This is the same environment within which pharmacists would conduct medicine-
related consultations with stroke survivors. 
 
4.3 Conclusion 
A consultation tool in two parts has been developed to support person-centred medicines 
consultations between stroke survivors and community pharmacists. The design reflected the needs 
and preferences of stroke survivors and the current working practice of community pharmacists based 
in the UK. This novel tool now needs to be fully evaluated to determine its feasibility for use in practice 
and the impact on patient care.   
 
4.4 Practice implications 
This research has a number of implications for community pharmacy practice but also much wider 
implications for the long-term care of stroke survivors. The methodology described could also help 
tailor medicines support for other patient groups who face difficulties in adhering long-term to their 




Pharmacists supporting stroke survivors must make more effort to identify stroke survivors in their 
care. This will require them, and perhaps their supporting staff, to be more proactive in asking 
whether patients on certain combinations of medicines likely to indicate a stroke whether they are 
stroke survivors. As SS often have limited awareness of the services that pharmacists can provide 
every opportunity to raise awareness of these should be made, for example by displaying posters 
advertising the medicine consultation service in the pharmacy.  Pharmacists can then use the tool to 
help optimise discussions with the SS; however, there may for some be a need to also extend their 
knowledge around the sequelae of stroke and managing consultations with patients with aphasia or 
other cognitive difficulties.  Pharmacists also need to be more aware of the environment in which they 
conduct consultations, and must ensure it is conducive to the needs of SS. A proportion of SS are 
unable to visit the pharmacy in person. Telephone conversations may not always be possible for this 
patient group. Pharmacists will need to consider how these patients can be supported, perhaps by 
having discussions with health care commissioners about the provision of domiciliary services.  
 
Stroke survivors need to be made more aware of the services available from pharmacists to support 
them in their medicine taking. This means that all members of the secondary care stroke team, and 
those providing long-term care in general practice also need to be aware of pharmacy services and 
signpost patients who appear to require medicines support. Ideally, formal referral processes need to 
be set in place, to ensure continuity of care within the stroke pathway, and which allow the pharmacist 
to access the medical notes to support them in their consultations and share their advice and actions 
with others caring for the patient. 
 
Finally, the format of this tool makes it usable by other health care professionals who may wish to 
provide medicines support. The methodology described could also be easily adapted to develop 
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Figure and Table legends – (no colour is required) 
Table 1: Participant Inclusion and Exclusion Criteria 
Table 2: Stroke Survivor Demographics 
Table 3: Community Pharmacist Demographics 
Figure 1: Stroke Survivor Framework 
Figure 2: Community Pharmacist Framework 
















       Inclusion criteria        Exclusion criteria  Possesses sufficient capacity to 
participate: ref Mental Capacity Act 
(Office of the Public Guardian 2005)  Has experienced an ischaemic 
stroke   Has been prescribed medication 
since stroke  18 years or older at the time of the 
study   Able to understand and 
communicate in English (i.e. 
verbal/reading)  Lives within the county of Kent (UK) 
or surrounding areas  Has access to and uses a regular 
community pharmacy   Has had a discussion with a 
community pharmacist within the 
last twelve months  
 Not in possession of sufficient 
capacity to participate: ref Mental 
Capacity Act (Office of the Public 
Guardian 2005)   Has not experienced stroke or 
stroke not of an Ischaemic nature  Has not been prescribed medication 
since stroke  Under 18 years of age  Not able to understand and 
communicate in English (i.e. 
verbal/reading)   Lives outside of the county of Kent 
(UK) or surrounding area  Does not have access to or use a 
regular community pharmacy  Has not had a discussion with a 
community pharmacist in the last 








 In possession of a UK recognised 
pharmacy qualification/registration   Is accredited to provide MUR/NMS  Is either a full time or part time 
pharmacist at one (regular) 
pharmacy  Has undertaken a patient 
consultation (i.e. MUR/NMS) at a 
community pharmacy within the last 
month  Is currently working within the 
county of Kent (UK)  
 
 Does not hold a UK recognised 
pharmacy qualification/registration 
at the time of the study  Is not accredited to provide 
MUR/NMS  Is not either a full time or part time 
pharmacist at one (regular) 
pharmacy  Has not undertaken patient 
consultation (i.e. MUR/NMS) at a 
community pharmacy within the last 
month  Is not currently working within the 




Table 2: Stroke Survivor Demographics 










modified Rankin scale 
(mRs) 
Live in support  
 (present at interview) 
1 F 73 39 6 Slight (2) Spouse 
2 M 66 25  5  Moderate (3) Spouse 
3 M 52 46  3 Moderately severe (4) Spouse  (at interview)         
4 F 88 35  2  Moderately severe (4) Sheltered housing staff 
5 M 65 39  1  Moderately severe (4)  Spouse (at interview)  
6 F 67 34  11 Moderate (3) Child 
7 M 65 75  9  Moderately severe (4) Spouse (at interview)          
8 F 91 24  2  Moderately severe (4) None – lives alone 
9 M 58 83  6  Moderately severe (4) Spouse 
10 M 70 45 6 Moderately severe (4) Spouse  
11 M 65 37  16 Moderately severe (4) Spouse 
12 F 48 36  10  Moderate (3) Spouse  
13 F 86 31 9 Moderately severe (4) None – lives alone  
14 F 80 38  3 Slight (mRs 2) Child 




Table 3: Community Pharmacist Demographics 
# Pharmacist characteristics: 
Gender/ 
Time qualified/Employment status 
Type of Pharmacy: 
Independent (I) 
Small multiple (S),  




       
Interview 
Duration  
1 Male/10-20 years/ Manager S Consultation room  37 mins 
2 Male/10-20 years/Owner I Pharmacy office 23 mins 
3 Female/20> years/ Manager L (supermarket) Consultation room  35 mins 








Male/20> years/ Manager 
L (supermarket) Consultation room  
 




7 Female/<10 years/ Manager L Consultation room  
 
37 mins 
8 Female/ /<10 years/ Owner  I Pharmacy office 27 mins 






Female/ 20> years/ Manager 
 
Female/20> years/ Locum 
























14 Female/10-20 years/Manager L (supermarket) Consultation room  
 
37 mins 
15 Male/ <10 years/ Manager S Consultation room  
 
37 mins 




































Impact of a stroke (i.e. 
cognitive/physical/psychological) 






centred SS/CP consultation   








awareness of & SS 
Personal factors 
Awareness: impact of a stroke 
Pt. relationships inc. SS 
Education & training 
 
Process factors 
Identification of SS 
Experience/approach to 
a SS consultation 
 
Environmental factors 
Environment for SS 
consultation 
Barriers & facilitators 
Other methods of contact 
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Figure 3: Consultation Tool  
A CONSULTATION TOOL TO OPTIMISE PERSON-CENTRED DISCUSSIONS ABOUT 
MEDICINES WITH STROKE SURVIVORS 
 
This tool is based on semi-structured interviews with stroke survivors and community pharmacists, 
research literature and recommendations from the Stroke Association 
 
It offers guidance for building a trusting relationship, promoting communication and identifying 
and resolving medicine-related problems with stroke survivors, which may encourage people 
to return to you for support  
 
 
STARTING OUT   It is important to identify stroke survivors - their needs might be specific and not 
obvious   Prescribed medicines provide a clue that a person has had a stroke - but you won’t 
know unless you ASK! Stroke survivors tell us they don’t mind being asked - they feel 
it is important for you to know  Stroke survivors want you to know how their stroke has affected them  
You could ask or invite the person to complete one of the ‘Getting to Know Me’ forms   
There are two versions of the form:  a) written  b) aphasia friendly   
Ask the stroke survivor which form they prefer to use  They would like you to know them as a person and to get to know you too   Find out if the stroke survivor wants someone with them during their discussion, such as 
spouse, relative or carer  Be sure to record all important information - this will mean that the stroke survivor does 
not have to repeat information to your colleagues and will always receive the best 
possible support  Stroke survivors would like you to have the latest knowledge and be a specialist about 




GETTING THE BEST FROM THE CONSULTATION 
Stroke survivors have told us the points below are important to them…  
 
Arranging to meet  Ensure you meet at a time suitable for the stroke survivor - some people feel better at 
different times of the day because of their stroke   Always allow sufficient time - discussions may take longer than usual 
 
Optimising the environment  Stroke survivors prefer a private, quiet and unconfined space - always ask the person if 
they prefer to talk in the consultation room  Choose a place where the stroke survivor, and possibly their carer, can sit down - it should 





Remember - some stroke survivors have difficulty visiting their pharmacy due to the 
effects of their stroke  
If possible, try to arrange other ways to meet with them, such as visiting their home 





Optimising communication  Take into account the individual’s specific needs before you start - you will probably need to 
explore these in more depth during the first consultation  
        Remember -  the patient is often an expert about living with their condition  Introduce yourself as the pharmacist, don’t assume stroke survivors know you as the 
pharmacist, and explain what you are going to do - i.e. to help them with their medicines   Don’t speak too quickly  Allow the person time to speak - listen actively and be sure to not interrupt or finish 
sentences    Keep sentences simple and concise  Don’t keep moving between topics - changing subjects quickly can be confusing  Don’t seem rushed - appear relaxed, approachable and that you have time  Use repetition - i.e. to reinforce important points and to check understanding 
(visually/verbally)   Make sure that you always include the stroke survivor in the discussion - keep face to face 
contact with the stroke survivor - especially in the presence of carers   Use communication tools wisely - they can be useful if someone has memory or 
communication difficulties - but leaflets are not any good if you cannot read   Sometimes it is better to ask short yes/no questions instead of open questions  Check reliability of responses - some stroke survivors may jumble their words - ‘no’ might 
mean ‘yes’! In such cases, tick/crosses or thumbs up/thumbs down may help  Ask if a break or rest is needed - notice verbal and non-verbal signs of fatigue  Taking notes during the consultation can communicate interest and attention, and 
support continuity of care. However, it should not be the focus or a distraction to the 
discussion - always ask if it is okay to take and keep notes  Be careful to not patronise - people can sometimes lack confidence after their stroke - 
remember stroke survivors are adults who have had a life-changing experience 
 
Remember - The Stroke Association has produced excellent guidance for helping to 
overcome communication difficulties with stroke survivors - search their website for their tips: 
www.stroke.org.uk/             
 
Developing joint-solutions to identified medicine-related problems  
Research has indicated that stroke survivors often do not identify or report medicines 
problems which could be easily resolved - by changes in presentation (formulation, 
packaging) or routine (dosage frequency, memory aids)  Make sure that you jointly recognise a problem and agree a solution  Consistency in the supply of medicines can be particularly important to stroke survivors - 
changes in brand should be limited and communicated  Remember to follow-up to see if the agreed solution has worked  It may be appropriate to liaise/share information with other healthcare professionals, ask 
the patient 
 
Helping stroke survivors recognise what you can do for them  Stroke survivors often have limited awareness of the support that pharmacists can 
provide - use every opportunity to share what services you provide - is there a poster 
advertising medicine support? You could also promote that you are sensitive to the 
specific needs of stroke survivors  Efficient and timely supply of medicines can be particularly important for stroke survivors 
and is a key factor in building trust, better relationships and opportunities for offering 
future support 
 
 
 
 
 
 
